Detalles de la búsqueda
1.
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?
Am J Gastroenterol
; 117(9): 1454-1461, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973177
2.
Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort study.
Liver Int
; 42(3): 561-574, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34951109
3.
Uptake of interferon-free DAA therapy among HCV-infected decompensated cirrhosis patients and evidence for decreased mortality.
J Viral Hepat
; 28(9): 1246-1255, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34002914
4.
Real-world utility of HCV core antigen as an alternative to HCV RNA testing: Implications for viral load and genotype.
J Viral Hepat
; 27(10): 996-1002, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32479681
5.
Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis.
J Viral Hepat
; 27(3): 270-280, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31696575
6.
Epidemiology of SARS-CoV-2 during the first three waves in Scotland: a national record linkage study.
J Epidemiol Community Health
; 2022 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36347597
7.
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection.
JHEP Rep
; 3(6): 100384, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34805817
Resultados
1 -
7
de 7
1
Próxima >
>>